Repligen
RGEN
#2476
Rank
NZ$12.76 B
Marketcap
NZ$226.42
Share price
1.31%
Change (1 day)
3.20%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): NZ$0.14 Billion

According to Repligen 's latest financial reports the company's current earnings are NZ$0.73 Billion. , an increase over its 2024 earnings that were of -NZ$10.68 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year Earnings Change
2025 NZ$0.14 B-1430.84%
2024 -NZ$10.68 Million-113.01%
2023 NZ$82.04 M-78.01%
2022 NZ$0.37 B33.37%
2021 NZ$0.27 B131.52%
2020 NZ$0.12 B101.31%
2019 NZ$60.01 M25.93%
2018 NZ$47.65 M105.61%
2017 NZ$23.17 M-11.46%
2016 NZ$26.18 M14.91%
2015 NZ$22.78 M20.26%
2014 NZ$18.94 M-51.49%
2013 NZ$39.05 M90.98%
2012 NZ$20.44 M
2010 NZ$0.29 M-103.81%
2009 -NZ$7.77 Million-223.84%
2008 NZ$6.27 M
2006 -NZ$4.22 Million229.64%
2005 -NZ$1.28 Million-89.16%
2004 -NZ$11.8 Million-16.86%
2003 -NZ$14.19 Million88.72%
2002 -NZ$7.52 Million-27.88%
2001 -NZ$10.43 Million-1.74%
2000 -NZ$10.61 Million85.93%
1999 -NZ$5.71 Million159.16%
1998 -NZ$2.21 Million85.71%
1997 -NZ$1.19 Million-70.83%
1996 -NZ$4.07 Million-72.41%
1995 -NZ$14.74 Million-60.63%
1994 -NZ$37.43 Million45.39%
1993 -NZ$25.74 Million39.45%
1992 -NZ$18.46 Million-32.3%
1991 -NZ$27.27 Million6.62%
1990 -NZ$25.57 Million1577.78%
1989 -NZ$1.53 Million-57.14%
1988 -NZ$3.56 Million-362.5%
1987 NZ$1.35 M-130.77%
1986 -NZ$4.41 Million136.36%
1985 -NZ$1.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$17.25 B 12,048.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$12.37 B 8,610.78%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$18.36 B 12,824.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$15.79 B 11,018.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-NZ$0.19 Billion-229.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ$0.63 B 346.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$1.07 B 658.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$0.20 B 47.18%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.81 B 475.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-NZ$0.17 Billion-218.60%๐Ÿ‡บ๐Ÿ‡ธ USA